MEP6808A - Priperidinoilpirodolini agonisti receptora menalokortina tipa 4 - Google Patents

Priperidinoilpirodolini agonisti receptora menalokortina tipa 4

Info

Publication number
MEP6808A
MEP6808A MEP-68/08A MEP6808A MEP6808A ME P6808 A MEP6808 A ME P6808A ME P6808 A MEP6808 A ME P6808A ME P6808 A MEP6808 A ME P6808A
Authority
ME
Montenegro
Prior art keywords
piperidinoylpyrrolidines
receptor agonist
melanocortin
melanocortin type
type
Prior art date
Application number
MEP-68/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Anette Graven Sams
Mogens Larsen
Gitte Mikkelsen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MEP6808A publication Critical patent/MEP6808A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MEP-68/08A 2006-02-23 2007-02-19 Priperidinoilpirodolini agonisti receptora menalokortina tipa 4 MEP6808A (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77629506P 2006-02-23 2006-02-23
US88784007P 2007-02-02 2007-02-02
PCT/IB2007/000456 WO2007096763A2 (en) 2006-02-23 2007-02-19 Melanocortin type 4 receptor agonist piperidinoylpyrrolidines

Publications (1)

Publication Number Publication Date
MEP6808A true MEP6808A (xx) 2010-02-10

Family

ID=38169450

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-68/08A MEP6808A (xx) 2006-02-23 2007-02-19 Priperidinoilpirodolini agonisti receptora menalokortina tipa 4

Country Status (21)

Country Link
US (1) US8138188B2 (pt)
EP (1) EP1989196B1 (pt)
KR (1) KR101036981B1 (pt)
AP (1) AP2008004602A0 (pt)
AU (1) AU2007219236B2 (pt)
BR (1) BRPI0708264A2 (pt)
CA (1) CA2642922C (pt)
CR (1) CR10219A (pt)
DK (1) DK1989196T3 (pt)
EA (1) EA200801738A1 (pt)
EC (1) ECSP088688A (pt)
ES (1) ES2402581T3 (pt)
IL (1) IL193279A (pt)
MA (1) MA30228B1 (pt)
ME (1) MEP6808A (pt)
MX (1) MX2008010899A (pt)
NO (1) NO20083480L (pt)
RS (1) RS20080371A (pt)
SG (1) SG185849A1 (pt)
TN (1) TNSN08337A1 (pt)
WO (1) WO2007096763A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2019100A1 (en) * 2007-07-19 2009-01-28 Santhera Pharmaceuticals (Schweiz) AG Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US8902867B2 (en) 2007-11-16 2014-12-02 Qualcomm Incorporated Favoring access points in wireless communications
US8848656B2 (en) 2007-11-16 2014-09-30 Qualcomm Incorporated Utilizing broadcast signals to convey restricted association information
US9603062B2 (en) 2007-11-16 2017-03-21 Qualcomm Incorporated Classifying access points using pilot identifiers
US8737295B2 (en) 2007-11-16 2014-05-27 Qualcomm Incorporated Sector identification using sector parameters signatures
EP2103614A1 (en) * 2008-03-18 2009-09-23 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators
US8588773B2 (en) 2008-08-04 2013-11-19 Qualcomm Incorporated System and method for cell search and selection in a wireless communication system
UA99555C2 (en) 2008-11-12 2012-08-27 Элджи Лайф Саенсез Лтд. Melanocortin receptor agonists
CN106512010A (zh) * 2009-11-18 2017-03-22 赫尔辛医疗股份公司 用于治疗中枢介导的恶心及呕吐的组合物及方法
EP2722045B1 (en) 2009-11-18 2016-07-06 Helsinn Healthcare SA Compositions for treating centrally mediated nausea and vomiting
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
PT3333165T (pt) 2015-08-04 2019-10-29 Astellas Pharma Inc Derivado de piperazina
EP3870292A4 (en) 2018-10-26 2022-11-09 The Research Foundation for The State University of New York COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA
PE20231215A1 (es) 2020-06-09 2023-08-17 Pfizer Compuestos espiro como antagonistas del receptor de melanocortina 4 y usos de los mismos
CA3241470A1 (en) 2021-12-06 2023-06-15 Pfizer Inc. Melanocortin 4 receptor antagonists and uses thereof
WO2025228892A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Monoaryl and hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament
WO2025228899A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Further heterocyclic compounds as sting antagonists and the use thereof as medicament
WO2025228889A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Monoarylic heterocyclic compounds as sting antagonists and the use thereof as medicament
US20250333414A1 (en) 2024-04-30 2025-10-30 Boehringer Ingelheim International Gmbh Hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament
WO2025228902A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Heterocyclic acids as sting antagonists and the use thereof as medicament
WO2025228900A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Arylamide substituted indazoles and the use thereof as medicament
US12605394B2 (en) 2024-07-25 2026-04-21 Visionary Assets, Llc Compositions containing cannabinoid nanoparticles

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (de) 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
GB8531071D0 (en) 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
US5274143A (en) 1991-07-23 1993-12-28 Hoffmann-La Roche Inc. Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2098167C (en) 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
US5596106A (en) 1994-07-15 1997-01-21 Eli Lilly And Company Cannabinoid receptor antagonists
DE4435477A1 (de) 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
US5521186A (en) 1994-10-27 1996-05-28 Janssen Pharmaceutica N.V. Apolipoprotein-β synthesis inhibitors
ES2155535T3 (es) 1994-10-27 2001-05-16 Janssen Pharmaceutica Nv Inhibidores de sintesis de apoliproteina b.
WO2000035298A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing gum containing medicament active agents
IL141769A0 (en) 1998-09-11 2002-03-10 Aventis Pharma Sa Azetidine derivatives, preparation and medicines containing them
FR2789079B3 (fr) 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
AU2002230843B8 (en) 2000-12-14 2007-05-17 Amylin Pharmaceuticals, Llc Peptide YY and peptide YY agonists for treatment of metabolic disorders
GEP20053710B (en) 2001-02-28 2005-12-26 Merck & Co Inc Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
EP1372653B1 (en) 2001-02-28 2006-10-04 Merck & Co., Inc. Acylated piperidine derivatives as melanocortin-4 receptor agonists
ATE284872T1 (de) 2001-03-22 2005-01-15 Solvay Pharm Bv 4,5-dihydro-1h-pyrazolderivate mit cb1- antagonistischer wirkung
AU2002353784B2 (en) 2001-09-24 2008-04-10 Oregon Health And Science University Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
EP1482794A1 (en) 2002-03-06 2004-12-08 Merck & Co., Inc. Method of treatment or prevention of obesity
MXPA05000962A (es) 2002-07-29 2005-05-16 Hoffmann La Roche Nuevos benzodioxoles.
US7091216B2 (en) 2002-08-02 2006-08-15 Merck & Co., Inc. Substituted furo[2,3-b]pyridine derivatives
US7129239B2 (en) 2002-10-28 2006-10-31 Pfizer Inc. Purine compounds and uses thereof
MY134457A (en) 2002-11-22 2007-12-31 Merck & Co Inc Substituted amides
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7141669B2 (en) 2003-04-23 2006-11-28 Pfizer Inc. Cannabiniod receptor ligands and uses thereof
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US7151097B2 (en) 2003-11-07 2006-12-19 Pfizer Inc. Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
GB0402492D0 (en) 2004-02-04 2004-03-10 Pfizer Ltd Pharmaceutically active compounds
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
WO2007015162A1 (en) * 2005-08-04 2007-02-08 Pfizer Limited Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
CA2731897C (en) 2008-08-06 2013-07-02 Pfizer Limited Diazepine and diazocane compounds as mc4 agonists

Also Published As

Publication number Publication date
DK1989196T3 (da) 2013-04-15
ES2402581T3 (es) 2013-05-06
ECSP088688A (es) 2008-10-31
HK1126489A1 (en) 2009-09-04
US20090036459A1 (en) 2009-02-05
EP1989196A2 (en) 2008-11-12
EA200801738A1 (ru) 2008-12-30
WO2007096763A3 (en) 2007-10-18
KR101036981B1 (ko) 2011-05-25
AU2007219236B2 (en) 2012-06-21
NO20083480L (no) 2008-09-10
TNSN08337A1 (fr) 2009-12-29
US8138188B2 (en) 2012-03-20
IL193279A (en) 2012-12-31
BRPI0708264A2 (pt) 2011-05-24
IL193279A0 (en) 2009-02-11
CR10219A (es) 2008-09-23
AU2007219236A1 (en) 2007-08-30
RS20080371A (sr) 2009-07-15
EP1989196B1 (en) 2013-02-13
WO2007096763A2 (en) 2007-08-30
CA2642922A1 (en) 2007-08-30
CA2642922C (en) 2011-08-02
SG185849A1 (en) 2012-12-28
KR20080095918A (ko) 2008-10-29
AP2008004602A0 (en) 2008-10-31
MX2008010899A (es) 2008-11-27
MA30228B1 (fr) 2009-02-02

Similar Documents

Publication Publication Date Title
WO2007096763A3 (en) Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
UA84208C2 (en) Tetraazabenzo(e)azulene derivatives and analogs thereof
EA200900658A1 (ru) Производные индазолилэфиров или -амидов для лечения расстройств, опосредованных глюкокортиодными рецепторами
TNSN08444A1 (en) Bicyclic derivatives as cetp inhibitors
MX2009008159A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
JO2701B1 (en) Vehicles
ATE455110T1 (de) 11-beta-hydroxysteroid-dehydrogenase-1-hemmer
ATE482210T1 (de) Oxadiazolderivate als s1p1-rezeptor-agonisten
JO2686B1 (en) Vehicles
ATE472542T1 (de) 11-beta-hydroxysteroid-dehydrogenase-1-hemmer
MX2008012400A (es) Azolopirimidinas como inhibidores de actividad de cannabinoide 1.
TW200732313A (en) Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
MY143581A (en) Carboxamide derivatives as muscarinic receptor antagonists
ZA200810031B (en) 1,3-disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their use for the manufacture of medicaments
UA97965C2 (ru) Замещенные пиразолы, содержащая их композиция, способ их получения и применения
TW200734323A (en) 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
TW200745122A (en) New compounds I
MY149973A (en) 3-carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists
DE602007007934D1 (en) Imidazoazephinonverbindungen
GB0621805D0 (en) Organic compounds
GB0513886D0 (en) Novel compounds
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
MX2007010572A (es) Compuestos de cinolina y su uso como moduladores de receptor x de higado.
UA102508C2 (ru) Производные индола как агонисты рецептора s1p1
TW200716090A (en) Inhibitors of soluble adenylate cyclase